Deficient TNF-α and IFN-γ production correlates with nondetectable donor-specific cytotoxicity after clinical kidney transplantation

Transplantation

Volumn 87, Issue 10, 2009, Pages 1451-1454

  Van Besouw, Nicole M ^a   De Kuiper, Ronella ^a   Van Der Mast, Barbara J ^a   Van De Wetering, Jacqueline ^a   Baan, Carla C ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CTL frequency; Cytokines; Donor specificity; Down regulation; Immunosuppression.

Indexed keywords

AZATHIOPRINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE ASSOCIATION; DONOR SELECTION; GRAFT REJECTION; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRE T LYMPHOCYTE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADRENAL CORTEX HORMONES; ANTIGENS, CD95; CYTOTOXICITY, IMMUNOLOGIC; DRUG THERAPY, COMBINATION; FAMILY; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; ISOANTIGENS; KIDNEY TRANSPLANTATION; LIVING DONORS; MONOCYTES; PROSPECTIVE STUDIES; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67649595496     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a36c85     Document Type: Article

References (19)

1. Gourishankar S, Turner P, Halloran P. New developments in immunosuppressive therapy in renal transplantation. Expert Opin Biol Ther2002; 2: 483.
2. Flechner SM, Kobashigawa J, Klintmalm G. Calcineurin inhibitorsparing regimens in solid organ transplantation: Focus on improving renal function and nephrotoxicity. Clin Transplant 2008; 22: 1.
3. van der Mast BJ, Rischen-Vos J, de Kuiper P, et al. Calcineurin inhibitor withdrawal in stable kidney transplant patients decreases the donorspecific cytotoxic T lymphocyte precursor frequency. Transplantation2005; 80: 1220.
4. Baker RJ, Hernandez-Fuentes MP, Brookes PA, et al. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001; 167: 7199.
5. Ng WF, Hernandez-Fuentes M, Baker R, et al. Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients. J Am Soc Nephrol2002; 13: 2983.
6. Najafian N, Albin MJ, Newell KA. How can we measure immunologic tolerance in humans? J Am Soc Nephrol 2006; 17: 2652.
7. Refaeli Y, Van Parijs L, Alexander SI, et al. Interferon gamma is required for activation-induced death of T lymphocytes. J Exp Med 2002; 196: 999.
8. Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 1988; 141: 2629.
9. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348.
10. Jiang S, Lechler RI, He XS, et al. Regulatory T cells and transplantation tolerance. Hum Immunol 2006; 67: 765.
11. Roncarolo MG, Gregori S, Battaglia M, et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006; 212: 28.
12. Georgescu L, Vakkalanka RK, Elkon KB, et al. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest 1997; 100: 2622.
13. Aung S, Graham BS. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo. J Immunol 2000; 164: 3487.
14. van Besouw NM, van der Mast BJ, de Kuiper P, et al. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 2000; 70: 136.
15. Golshayan D, Buhler L, Lechler RI, et al. From current immunosuppressive strategies to clinical tolerance of allografts. Transpl Int 2007; 20: 12.
16. Gras J, Wieers G, Vaerman JL, et al. Early immunological monitoring after pediatric liver transplantation: Cytokine immune deviation and graft acceptance in 40 recipients. Liver Transpl 2007; 13: 426.
17. Appleman LJ, Boussiotis VA. T cell anergy and costimulation. Immunol Rev 2003; 192: 161.
18. Schutz C, Fleck M, Mackensen A, et al. Killer artificial antigen-presenting cells: A novel strategy to delete specific T cells. Blood 2008; 111: 3546.
19. Mathew JM, Marsh JW, Susskind B, et al. Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation. J Clin Invest 1993; 91: 900.